Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2008-05-13
2008-05-13
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S234100, C424S190100, C424S184100, C514S002600
Reexamination Certificate
active
07371394
ABSTRACT:
A novel antigen fromP. aeruginosais provided. The use of the antigen in detecting/diagnosingP. aeruginosaas well as its use in eliciting an immune response are also provided.
REFERENCES:
patent: 4946677 (1990-08-01), Dorner et al.
patent: 5237053 (1993-08-01), Dorner et al.
patent: 0252064 (1987-06-01), None
patent: 0717106 (1995-11-01), None
patent: 9006696 (1990-06-01), None
patent: 9324636 (1993-12-01), None
patent: 9741234 (1997-11-01), None
Parkhill J et al., as published Oct. 15, 2001, “catalase [Yersinia pestis]” Genbank Accession No. NP—404811 GI:16121498.
Stover CK et al., as published Sep. 10, 2001, “catalase [Pseudomonas aeruginosa]” Genbank Accession No. NP—252926.1 GI:15599432.
Greenberg EP, 2000, “Bacterial genomics: pump up the versatility”Nature406(6799):947-948.
Stover CK et al., 2000, “Complete genome sequence ofPseudomonas aeruginosaPA01, an opportunistic pathogen”Nature406(6799):959-964.
Ma J et al., 1999, “Bacterioferritin A modulates catalase A (Kat A) activity and resistance to hydrogen peroxide inPseudomonas aeruginosa” Journal of Bacteriology181(12):3730-3742.
Nurizzo et al., 1997, Structure 5(9):1157-1171. N-terminal arm exchange is observed in the 2.15 A crystal structure of oxidized nitrite reductase fromPseudomonas aeruginosa.
Brown et al., 1995, J Bacteriol. 177(22):6536-44. Cloning and characterization of the katB gene ofPseudomonas aeruginosaencoding a hydrogen peroxide-inducible catalase: purification of KatB, cellular localization, and demonstration that it is essential for optimal resistance to hydrogen peroxide.
Yamano et al., 1994, Appl Microbiol Biotechnol 40:892-897. Ferric iron transport system ofPseudomonas aeruginosaPA01 that functions as the uptake pathway of a novel catechol-substituted cephalosporin, S-9096.
Sipos et al., 1991, Infect Immun. 59(9):3219-26. Cloning and sequencing of the genes coding for the 10- and 60-kDa heat shock proteins fromPseudomonas aeruginosaand mapping of a species-specific epitope.
Burgess et al., 1990, J Cell Biol. 111(5 Pt 1):2129-38. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.
Meyer et al., 1990, Mol Microbiol. 1990 4(8):1401-5. Pyoverdin-facilitated iron uptake inPseudomonas aeruginosa: immunological characterization of the ferripyoverdin receptor.
Yamano et al., 1990, J Antimicrob Chemother. 26(2):175-84. Outer membrane proteins responsible for the penetration of beta-lactams and quinolones inPseudomonas aeruginosa.
Barbhaiya and Rao, 1988, FEMS Microbiology Letts 51:169-172. Iron uptake and detection of an outer membrane iron-siderophore receptor protein fromPseudomonas aeruginosaPA01.
Kukor et al., 1988 J Bacteriol. 170(10):4458-65. Cloning and expression of the catA and catBC gene clusters fromPseudomonas aeruginosaPAO.
Lazar et al., 1988, Mol Cell Biol. 8(3):1247-52. Transforming growth factor alpha: mutation of aspartic acid 47 and leucine 48 results in different biological activities.
Yamaguchi et al., 1986, Japanese Journal of Bacteriology [Nippon Saikingaku Zasshi] 41(4):701-7. [Article in Japanese] The characterization of cross-reacting protein antigens in gram-negative bacilli.
Fernandes et al., 1981, Infect Immun. 33(2):527-32. Antibodies to cell envelope proteins ofPseudomonas aeruginosain cystic fibrosis patients.
Sompolinsky et al., 1980 Acta Pathol Microbiol Scand [B]. 88(5):253-60An antigen common to a wide range of bacteria. 2. A biochemical study of a “common antigen” fromPseudomonas aeruginosa.
Clancy Robert Llewellyn
Cripps Allan William
Dunkley Margaret
Kyd Jennelle
Auspharm International Limited
Baker & Botts L.L.P.
Devi S.
LandOfFree
Antigenic composition of a Pseudomonas aeruginosa protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigenic composition of a Pseudomonas aeruginosa protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic composition of a Pseudomonas aeruginosa protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2754284